Skip to content

Tesofensine

Weight & metabolicdrug

Availability Not yet prescribable · sold for research use only

What it is

Tesofensine is a triple monoamine reuptake inhibitor, blocking the reabsorption of dopamine, noradrenaline, and serotonin in the brain. It was developed for Parkinson's and Alzheimer's disease, failed in both, and was noticed in those trials for an unintended effect: participants lost weight. It has been chasing an obesity approval ever since.

Why people take it

It is an oral appetite suppressant with striking trial numbers, in a market where the drugs that work are injections. It appears on frontier clinic menus and in vendor catalogs as the pill alternative to GLP-1 therapy, frequently described as approved somewhere, which is the point at which the story stops matching the record.

How it's delivered

An oral capsule taken daily, in the range of 0.25 to 0.5 mg in the studies. Because it raises dopamine and noradrenaline centrally, it also raises heart rate and blood pressure in a dose-related way, and effects on mood and sleep are reported. Anything bought outside a trial carries no verified dose and no manufacturer standing behind it.

Where the evidence stands

A strong Phase 2 carrying an asterisk, then a long stall. The 2008 TIPO-1 trial randomized 203 adults with obesity for 24 weeks and reported mean weight loss of 9.2 percent at 0.5 mg and 10.6 percent at 1 mg against 2.0 percent on diet and placebo, with heart rate up more than 7 beats per minute at the middle dose. In 2013 The Lancet issued an expression of concern about that paper, never resolved or withdrawn, and it remains the trial every menu quotes. A Phase 3 program ran in Mexico and an application followed. Mexican regulators issued a non-binding favorable technical opinion in 2023, which the developer stated was neither an authorization nor a rejection, and no approval has been granted since, in Mexico or anywhere else.

Estimated cost

With no marketing authorization anywhere, there is no reference price. Clinics that carry it price it as a program add-on rather than publishing a list price, insurance never covers it, and no verified dose exists outside the trials.

Who offers it

  • ClinicNext Health
How we know

Observed in provider menus on our last research pass; each listing is stamped when verified. We may be compensated when you contact providers through Longevity.io; payment never affects ranking.

Go deeper

No tesofensine guide yet. Our GLP-1 guide covers the approved weight drugs and the evidence behind them, which is the comparison a menu listing tesofensine is inviting you to make.

Explore GLP-1s and longevity

Longevity.io is for educational purposes only and is not medical advice. Tesofensine has no marketing authorization in the United States, and any clinician offering it is working outside the approval system. Confirm eligibility, services, and pricing directly with any provider.

Your Longevity Blueprint

Build your starting plan.

A few short questions, about two minutes. The Blueprint recommends where to start and explains why.

Build my Blueprint